Innovation is of no worth if it doesn’t provide better outcomes for patients. Indeed, such advancements should hold as centre the amelioration of the overall patient experience.
Precision medicine is oft spoken about these days, as it is finally addressing the elephant in the room: one size – or, more appropriately, one dose – does not fit all.
In the pharmaceutical research field, the journey from laboratory to pharmacy shelf is fraught with challenges, such as the high failure rates and increasing costs of clinical trials.
September was a significant month for the companies that support the life sciences industry like CROs, CDMOs, and suppliers, as well as digital health companies.
Healthcare is getting more and more complex, demanding, and costly – and both patients and pharmacists are feeling the effects of a post-pandemic world.
A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.